Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
COAG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COAG recently traded at $26.47. Market cap is $1.27B. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $26.47 |
| Market Cap | $1.27B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.61 |
| 52-Week Low | $23.00 |
| Volume | 206 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
COAG analyst coverage data. Average price target: $0.00.